Probiotics inhibit enteropathogenic E. coliadherence in vitro by inducing intestinal mucin gene expression.

The hypothesis is that the ability of probiotic agents to inhibit adherence of attaching and effacing organisms to intestinal epithelial cells is mediated through their ability to increase expression of MUC2 and MUC3 intestinal mucins.